[PDF][PDF] Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer

KR Hess, K Anderson, WF Symmans, V Valero… - Journal of clinical …, 2006 - Citeseer
KR Hess, K Anderson, WF Symmans, V Valero, N Ibrahim, JA Mejia, D Booser, RL Theriault…
Journal of clinical oncology, 2006Citeseer
Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and
Fluorouracil, Doxorubicin, and Cycloph Page 1 Pharmacogenomic Predictor of Sensitivity to
Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and
Cyclophosphamide in Breast Cancer Kenneth R. Hess, Keith Anderson, W. Fraser Symmans,
Vicente Valero, Nuhad Ibrahim, Jaime A. Mejia, Daniel Booser, Richard L. Theriault, Aman U.
Buzdar, Peter J. Dempsey, Roman Rouzier, Nour Sneige, Jeffrey S. Ross, Tatiana Vidaurre …
Purpose
We developed a multigene predictor of pathologic complete response (pCR) to preoperative weekly paclitaxel and fluorouracil-doxorubicin-cyclophosphamide (T/FAC) chemotherapy and assessed its predictive accuracy on independent cases.
Citeseer